Cited by 289Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction

Thenappan, Thenappan, Shah, Sanjiv J., Gomberg-Maitland, Mardi, Collander, Brett, Vallakati, Ajay, Shroff, Pranavkumar, Rich, Stuart·2011·Circulation Heart Failure

Abstract

BACKGROUND: Pulmonary vascular disease associated with left-side heart failure and preserved ejection fraction (PH-HFpEF) is an increasingly common cause of pulmonary hypertension. The distinction between PH-HFpEF and pulmonary arterial hypertension (PAH) is important because therapies indicated for PAH can be detrimental in HFpEF. The characteristic features of PH-HFpEF are understudied. METHODS AND RESULTS: In a cross-sectional study, we compared the clinical, echocardiographic, and hemodynamic features of PH-HFpEF (n=100), with PAH (n=522), and HFpEF without pulmonary vascular disease (n=45). We determined the clinical characteristics that best differentiated PH-HFpEF from PAH. Compared with patients with PAH, patients with PH-HFpEF were older; had a higher prevalence of cardiovascular comorbidities; had worse exercise capacity and renal function; more frequently had left atrial enlargement; and less frequently had right atrial enlargement. PH was less severe in PH-HFpEF patients than in PAH patients (pulmonary vascular resistance 4.8 [interquartile range 3 to 8.4] versus 10.9 [interquartile range 7.4 to 15.7] Wood units; P<0.001). Old age, the presence of hypertension and coronary artery disease, the absence of right atrial enlargement, higher aortic systolic pressure, higher mean right atrial pressure, and higher cardiac output best differentiated PH-HFpEF from PAH (area under the receiver operating characteristics curve; curve 0.97). Compared with HFpEF patients without pulmonary hypertension, PH-HFpEF patients were often female and more symptomatic, more often had right ventricular hypertrophy and right atrial enlargement, and had higher right atrial pressure. CONCLUSIONS: These data should help better identify PH-HFpEF, an entity that has become increasingly recognized and difficult to treat.

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.110.958801

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S.
Affiliations
  • Northwestern University (US)
  • From the Section of Cardiology (T.T., M.G.M., S.R.), Department of Medicine, University of Chicago, Chicago, IL and the Division of Cardiology (S.S., B.C., A.V., P.S.), Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Venue
Circulation Heart Failure
Published
2011-05
Volume
4
Issue
3
Pages
257-265
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2120117348
Cited by
289
References
37
Citations by year
2026: 6 · 2025: 5 · 2024: 11 · 2023: 13 · 2022: 14 · 2021: 23 · 2020: 17 · 2019: 12 · 2018: 18 · 2017: 30 · 2016: 34 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 20
FWCI
20.13
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
pulmonary hypertension, heart failure with preserved ejection fraction, pulmonary vascular disease, pulmonary arterial hypertension, differential diagnosis, pulmonary vascular resistance, right atrial pressure, right ventricular hypertrophy, left atrial enlargement, exercise capacity, renal function, cardiovascular comorbidity, echocardiographic features
MeSH terms
Aged, Cross-Sectional Studies, Female, Heart Failure, Humans, Hypertension, Pulmonary, Male, Middle Aged, Stroke Volume

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review